Vaxil Bio Ltd.

13F holders, Q3 2024 (September 30)
1holders
0new positions
0sold out
$0.01avg. 13F price*

At the end of Q3 2024, 1 institutions reported holding Vaxil Bio Ltd. in their 13F filings, unchanged from Q2 2024. 0 opened new positions and 0 sold out. The largest holder was Carret Asset Management, LLC ($100).

Company
Vaxil Bio Ltd.
CUSIP
92243L107
Latest filing quarter
Q1 2025

History

Number of 13F holders

012 Q1 2024: 2Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions0$0
Exits0$0

Ownership 1 holders

Carret Asset Management, LLC 0.00% No change 20,000 $100

"% of holder's portfolio" is VAXIL BIO LTD's weight in each manager's 13F, not the share of Vaxil Bio Ltd. the manager owns.